Coronavirus Notebook: Moderna To Build UK Vaccines Plant, US Approves First MAb For COVID-19
Sanofi/GSK’s VidPrevtyn Beta has become the seventh COVID-19 vaccine to be approved by the UK regulator, the MHRA.
You may also be interested in...
Moderna says that if the right investments are made in reforming the Medicines and Healthcare products Regulatory Agency, the National Health Service and other public health bodies, the UK will be in a strong position to mitigate “future shocks” in the health care system.
The European Medicines Agency said it was possible to use immunobridging studies to authorize COVID-19 vaccines now that a number of COVID-19 vaccines authorized in the EU are proven to be safe and effective and can be used as comparators in trials.
The head of the European Medicines Agency says a group of international regulators got together to ensure “global alignment” on the approach to be taken on COVID-19 vaccination.